Comparable Effects Of Regular Treatment With Combination Of Salmeterol/fluticasone Propionate And Long-Acting Beta2-Agonist In Cough Variant Asthma

被引：0
|
作者：
Tagaya, E. [1 ]
Okude, A. [1 ]
Akaba, T. [1 ]
Kirishi, S. [1 ]
Kondo, M. [1 ]
Isono, K. [2 ]
Tamaoki, J. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
[2] Nishi Sayama Hosp, Saitama, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1351
引用
收藏
页数：1
相关论文
共 50 条
  • [31] An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma
    Usmani, Omar
    Roche, Nicolas
    Marshall, Jonathan
    Danagher, Helen
    Price, David
    EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (12) : 1367 - 1380
  • [32] Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases
    Beeh, Kai M.
    Beier, Jutta
    ADVANCES IN THERAPY, 2009, 26 (07) : 691 - 699
  • [33] Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
    Lotvall, Jan
    Bateman, Eric D.
    Busse, William W.
    O'Byrne, Paul M.
    Woodcock, Ashley
    Toler, William T.
    Jacques, Loretta
    Goldfrad, Caroline
    Bleecker, Eugene R.
    JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2014, 13
  • [34] Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
    Ximena Rojas-Reyes, Maria
    Garcia Morales, Olga M.
    Dennis, Rodolfo J.
    Karner, Charlotta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (06): : CD008532
  • [35] Inhaled corticosteroid/long-acting beta2-agonist(ICS/LABA) new-user analysis: identifying asthma-exacerbation/short-acting beta2-agonist (SABA) overuse-associated characteristics
    Hamouda, Mohamed
    Quint, Jennifer
    Rendon, Adrian
    Stanford, Richard
    Gemicioglu, Bilun
    Fritscher, Leandro
    Boonsawat, Watchara
    Khan, Shireen Quli
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [36] SALMETEROL IN NOCTURNAL ASTHMA - A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF A LONG-ACTING INHALED BETA-2 AGONIST
    FITZPATRICK, MF
    MACKAY, T
    DRIVER, H
    DOUGLAS, NJ
    BRITISH MEDICAL JOURNAL, 1990, 301 (6765): : 1365 - 1368
  • [37] Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
    Karner, C.
    Cates, C. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [38] Asthma treatment in children and adolescents with fixed combination of inhaled corticosteroid (ICS)/long-acting beta 2 agonist (LABA). An update
    Gappa, Monika
    PNEUMOLOGE, 2021, 18 (05): : 320 - 325
  • [39] ECONOMIC EVALUATION OF FLUTICASONE PROPIONATE/SALMETEROL COMBINATION THERAPY AND MONTELUKAST IN ADULT PATIENTS WHO ARE SYMPTOMATIC ON SHORT-ACTING BETA 2-AGONIST ALONE
    Rely, K.
    Gonzalez, S. E.
    Salinas, G. E.
    Alexandre, P. K.
    VALUE IN HEALTH, 2010, 13 (07) : A323 - A323
  • [40] Long-acting β2-agonist bronchodilators safety for asthma treatment
    Giubergia, Veronica
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2009, 107 (04): : 291 - 293
12345